Price Move History
- Daily moves over 5%
- 20 42 sessions, December 31, 2021 to March 15, 2022
- Largest daily move
- +58.3% close of March 2, 2022
- 1-month change
- -14.9% closing prices, February 15, 2022 to March 15, 2022
Company Description
Claritas Pharmaceuticals (OTC: KALTF) is classified in the biotechnology industry within the Healthcare sector.
KALTF declined 27.2% in the year to March 15, 2022. The last closing price was $0.1100.
This page collects what Stock Titan holds for KALTF, including price data and latest news.
Stock Performance
Claritas Pharmaceuticals (KALTF) closed at $0.1100 on March 15, 2022. In the year to March 15, 2022, the price lost 27.2%.
KALTF Metrics & Rankings
Price returns through March 15, 2022. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
Claritas Pharmaceuticals has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 2 with negative movement. Key topics include clinical trial, acquisition. View all KALTF news →
SEC Filings
KALTF Company Profile & Sector Positioning
Claritas Pharmaceuticals (KALTF) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing KALTF often look at related companies in the same sector, including Vertex Pharmaceuticals Inc (VRTX), Regeneron Pharmaceuticals Inc (REGN), Moderna, Inc. (MRNA), argenx SE (ARGX), and BeOne Medicines Ltd. (ONC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate KALTF's relative position within its industry.